CLINICAL_TRIALS
trial_result
· 2010-07-09
Clinical Trial Update: An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) [Phase 3]
Summary
This is a completed Phase 3 clinical trial update evaluating the immunogenicity and safety of Gardasil in Chinese subjects.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Papillomavirus Infections | Phase 3 | Status: COMPLETED | Results posted: 2010-07-09